Skip to main content
Log in

Pediatric Medulloblastoma: Prognostic Value of p53, bcl-2, Mib-1, and Microvessel Density

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The aim of this study was to retrospectively assess the prognostic value of p53 and bcl-2 protein expression, cell proliferation index (Mib-1 index), and tumor microvessel density (factor VIII-related antigen) in pediatric medulloblastoma patients. Tumor specimens of 55 patients (age 2–18 years) with medulloblastoma treated with a curative intent between 1972 and 1991 were studied. Slides of paraffin embedded tissue were stained with monoclonal antibodies (mAb) and examined under high power light microscopy for the presence of immunoreactivity. Microvessel density was scored both in the area of most intense staining (‘Angio-max’) and in 3 additional randomly selected areas. The sum of these 4 scores was termed ‘Angio-total’. ‘Angio-max’ and ‘Angio-total’ were evaluated separately by two independent investigators to assess reproducibility. None of the parameters studied, i.e. p53 or bcl-2 expression, Mib-1 index or microvessel density scores were associated with patient survival. Microvessel scores between observers were significantly but weakly correlated, with correlation coefficients (r)<0.5 for both ‘Angio-max’ and ‘Angio-total’. Leptomeningeal spread at diagnosis was the only independent factor associated with a poor survival (p=0.003). There was no association of leptomeningeal metastasis with any of the biological markers tested in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yasue M, Tomita T, Engelhard H, Gonzalez-Crussi F, McLone DG, Bauer KD: Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg 70: 385–391, 1989

    Google Scholar 

  2. Tait DM, Eeles RA, Carter R, Ashley S, Ormerod MG: Ploidy and proliferative index in medulloblastoma: useful prognostic factors? Eur J Cancer 29A: 1383–1387, 1993

    Google Scholar 

  3. Gajjar AJ, Heideman RL, Douglass EC, Kun LE, Kovnar EH, Sanford RA, Fairclough DL, Ayers D, Look AT: Relation of tumor-cell ploidy to survival in children with medulloblastoma. J Clin Oncol 11: 2211–2217, 1993

    Google Scholar 

  4. Ito S, Hoshino T, Prados MD, Edwards MSB: Cell kinetics of medulloblastomas. Cancer 70: 671–678, 1992

    Google Scholar 

  5. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human central nervous system tumors: a study withMIB1 monoclonal antibody on archival material. Acta Neuropathol 87: 47–54, 1994

    Google Scholar 

  6. Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L: Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol 87: 362–370, 1994

    Google Scholar 

  7. Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD: Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50: 2347–2350, 1990

    Google Scholar 

  8. MacGregor DN, Ziff EB: Elevated c-myc expression in childhood medulloblastomas. Pediatr Res 28: 63–68, 1990

    Google Scholar 

  9. McDonald JD, Daneshvar L, Willert JR, Matsumura K, Waldman F, Cogen PH: Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23: 229–232

  10. Batra SK, McLendon RE, Koo JS, Castellino-Prabhu S, Fuchs HE, Krisher JP, Friedman HS, Bigner DD, Bigner SH: Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neuro-Oncol 24: 39–45, 1995

    Google Scholar 

  11. Weidner N, Semple JP, Welch WR, Folkman J:Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1–8, 1991

    Google Scholar 

  12. Germano IM, Ito M Cho KG, Hoshino T, Davis RL, Wilson CB: Correlation of histopathological features and proliferative potential of gliomas. J Neurosurg 70: 701–706, 1989

    Google Scholar 

  13. Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344: 82–86, 1994

    Google Scholar 

  14. Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362–372, 1996

    Google Scholar 

  15. Chang CH, Housepian EM, Herbert Jr CJ: An operative staging and amegavoltage radiotherapy technique for cerebellar medulloblastoma. Radiology 93: 1351–1359, 1969

    Google Scholar 

  16. Newcomb EW, Bhalla SK, Parrish CL, Hayes RL, Cohen H, Miller DC: bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 94: 369–375, 1997

    Google Scholar 

  17. Ohkoudo M, Sawa H, Hara M, Saruta K, Aiso T, Ohki R, Yamamoto H, Maemura E, Shiina Y, Fujii M, Saitu: Expression of p53, MDM2 protein, and Ki-67 antigen in recurrent meningiomas. J Neuro-Oncol 38: 41–49, 1998

    Google Scholar 

  18. Jaros E, Lunec J, Perry RH, Kelly PJ, Pearson ADJ: p53 protein overexpression identifies a group of central primitive neuroectodermal tumors with poor prognosis. Br J Cancer 68: 801–807, 1993

    Google Scholar 

  19. Saylors RL III, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51: 4721–4723, 1991

    Google Scholar 

  20. Hui-Kuo SG, Burman F, Dee S, Israel MA: Differential induction of p53-mediated apoptosis in medulloblastomas and gliomas correlates with their ability to induce bax. Int J Radiat Oncol Biol Phys 39(suppl): 178, 1997

    Google Scholar 

  21. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336, 1990

    Google Scholar 

  22. Korsmeyer SJ: bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879–886, 1992

    Google Scholar 

  23. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, Reed JCI: Immunohistochemical analysis of bcl-2, bcl-x, mcl-1, and bax in tumors of central and peripheral nervous system origin.AmJ Pathol 150: 805–814, 1997

    Google Scholar 

  24. Heck K, Pyle P, Bruner JH: bcl-2 expression in cerebellar medulloblastomas. Brain Pathol 4: 438, 1994

    Google Scholar 

  25. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa H: bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 88: 520–526, 1994

    Google Scholar 

  26. Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L: bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study. J Neuro-Oncol 27: 101–109, 1996

    Google Scholar 

  27. Ballantyne ES, McDowell H, May PL, Gosden C: Childhood medulloblastoma: bcl-2 expression and survival. J Neuro-Oncol 30: 99, 1996

    Google Scholar 

  28. Oka H, Satoh Y, Kawano N, Yagishita S, Kameya T: Expression of bcl-2 gene product in embryonal tumors of the central nervous system. Surg Neurol 45: 230–235, 1996

    Google Scholar 

  29. Alderson LM, Castleberg RL, Harsh GR, Louis DN, Henson JW: Human gliomas with wild-type p53 express bcl-2. Cancer Res 55: 999–1001, 1995

    Google Scholar 

  30. Ellison DW, Steart PV, Gatter KC, Weller RO: Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol Appl Neurobiol 21: 352–361, 1995

    Google Scholar 

  31. Jay V, Parkinson D, Becker L, Chan FW: Cell kinetic analysis in pediatric brain and spinal tumors: a study of 117 cases with Ki-67 quantification and flowcytometry. Pediatr Pathol 14: 253–276, 1994

    Google Scholar 

  32. Weidner N: Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184: 119–122, 1998

    Google Scholar 

  33. Wesseling P, Ruiter DJ, Burger PC: Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neuro-Oncol 32: 253–265, 1997

    Google Scholar 

  34. Pietsch T, Valter MM, Wolf HK, Von Deimling A, Su Huang HJ, Cavenee WK, Wiestler OD: Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93: 109–117, 1997

    Google Scholar 

  35. Taomoto K, Tomita T, Raimondi AJ, Leestma JE: Medulloblastomas in childhood: histological factors influencing patient's outcome. Child Nerv Syst 3: 354–360, 1987

    Google Scholar 

  36. Vermeulen PB, Gasparini SB, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY: Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474–2484

  37. Barbareschi M, Weidner N, Gasparini G: Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided analysis system. Appl Immunohistochem 3: 75–84, 1995

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miralbell, R., Tolnay, M., Bieri, S. et al. Pediatric Medulloblastoma: Prognostic Value of p53, bcl-2, Mib-1, and Microvessel Density. J Neurooncol 45, 103–110 (1999). https://doi.org/10.1023/A:1006330324991

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006330324991

Navigation